These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 3710012

  • 21. Antihypertensive treatment: long-term reversal of progression of albuminuria in incipient diabetic nephropathy. A longitudinal study of renal function.
    Christensen CK, Mogensen CE.
    J Diabet Complications; 1987; 1(2):45-52. PubMed ID: 2969901
    [Abstract] [Full Text] [Related]

  • 22. Blood pressure changes and renal function in incipient and overt diabetic nephropathy.
    Mogensen CE, Christensen CK.
    Hypertension; 1985; 7(6 Pt 2):II64-73. PubMed ID: 3878334
    [Abstract] [Full Text] [Related]

  • 23. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure.
    Christensen CK, Mogensen CE.
    Diabet Med; 1985 Mar; 2(2):97-102. PubMed ID: 2952409
    [Abstract] [Full Text] [Related]

  • 24. Rosiglitazone improves glomerular hyperfiltration, renal endothelial dysfunction, and microalbuminuria of incipient diabetic nephropathy in patients.
    Pistrosch F, Herbrig K, Kindel B, Passauer J, Fischer S, Gross P.
    Diabetes; 2005 Jul; 54(7):2206-11. PubMed ID: 15983223
    [Abstract] [Full Text] [Related]

  • 25. Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study.
    Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, Cambien F.
    BMJ; 1996 Sep 07; 313(7057):591-4. PubMed ID: 8806248
    [Abstract] [Full Text] [Related]

  • 26. Effect of aldose reductase inhibitor (tolrestat) on urinary albumin excretion rate and glomerular filtration rate in IDDM subjects with nephropathy.
    Passariello N, Sepe J, Marrazzo G, De Cicco A, Peluso A, Pisano MC, Sgambato S, Tesauro P, D'Onofrio F.
    Diabetes Care; 1993 May 07; 16(5):789-95. PubMed ID: 8495620
    [Abstract] [Full Text] [Related]

  • 27. Impact of arterial blood pressure and albuminuria on the progression of diabetic nephropathy in IDDM patients.
    Rossing P, Hommel E, Smidt UM, Parving HH.
    Diabetes; 1993 May 07; 42(5):715-9. PubMed ID: 8482428
    [Abstract] [Full Text] [Related]

  • 28. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy.
    Ranganathan S, Krempf M, Feraille E, Charbonnel B.
    Diabete Metab; 1993 May 07; 19(2):257-61. PubMed ID: 8339858
    [Abstract] [Full Text] [Related]

  • 29. Effective postponement of diabetic nephropathy with enalapril in normotensive type 2 diabetic patients with microalbuminuria.
    Ahmad J, Siddiqui MA, Ahmad H.
    Diabetes Care; 1997 Oct 07; 20(10):1576-81. PubMed ID: 9314638
    [Abstract] [Full Text] [Related]

  • 30. The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy.
    Mogensen CE, Christensen CK, Vittinghus E.
    Diabetes; 1983 May 07; 32 Suppl 2():64-78. PubMed ID: 6400670
    [Abstract] [Full Text] [Related]

  • 31. Glomerular structure in IDDM women with low glomerular filtration rate and normal urinary albumin excretion.
    Lane PH, Steffes MW, Mauer SM.
    Diabetes; 1992 May 07; 41(5):581-6. PubMed ID: 1568527
    [Abstract] [Full Text] [Related]

  • 32. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group.
    Laffel LM, McGill JB, Gans DJ.
    Am J Med; 1995 Nov 07; 99(5):497-504. PubMed ID: 7485207
    [Abstract] [Full Text] [Related]

  • 33. Treatment with atenolol prevents progression of microalbuminuria in type I diabetic patients.
    Tindall H, Urquhart S, Stickland M, Davies JA.
    Curr Med Res Opin; 1991 Nov 07; 12(8):516-20. PubMed ID: 1764955
    [Abstract] [Full Text] [Related]

  • 34. Hypotensive therapy reduces microvascular albumin leakage in insulin-dependent diabetic patients with nephropathy.
    Parving HH, Smidt UM.
    Diabet Med; 1986 Nov 07; 3(4):312-5. PubMed ID: 2949917
    [Abstract] [Full Text] [Related]

  • 35. Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study.
    Rudberg S, Persson B, Dahlquist G.
    Kidney Int; 1992 Apr 07; 41(4):822-8. PubMed ID: 1513104
    [Abstract] [Full Text] [Related]

  • 36. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study.
    Gall MA, Hougaard P, Borch-Johnsen K, Parving HH.
    BMJ; 1997 Mar 15; 314(7083):783-8. PubMed ID: 9080995
    [Abstract] [Full Text] [Related]

  • 37. Short-term effect of angiotensin-converting enzyme inhibitor enalapril in incipient diabetic nephropathy.
    Abu-Romeh SH, Nawaz MK, Ali JH, Al-Suhaili AR, Abu-Jayyab AK.
    Clin Nephrol; 1989 Jan 15; 31(1):18-21. PubMed ID: 2536602
    [Abstract] [Full Text] [Related]

  • 38. Studies of cardiovascular and renal function in subclinical and manifest diabetic nephropathy.
    Berglund J.
    Acta Med Scand Suppl; 1988 Jan 15; 722():1-69. PubMed ID: 3163465
    [Abstract] [Full Text] [Related]

  • 39. The effect of metabolic control on rate of decline in renal function in insulin-dependent diabetes mellitus with overt diabetic nephropathy.
    Mulec H, Blohmé G, Grände B, Björck S.
    Nephrol Dial Transplant; 1998 Mar 15; 13(3):651-5. PubMed ID: 9550642
    [Abstract] [Full Text] [Related]

  • 40. Urinary excretion rate of NC1 and Tamm-Horsfall protein in the microalbuminuric type I diabetic patient.
    Torffvit O, Agardh CD.
    J Diabetes Complications; 1994 Mar 15; 8(2):77-83. PubMed ID: 8061350
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.